Beijing Tiantan Biological Products Corporation Limited’s Net Profit Dropped 22.8% in First Quarter of 2022

Beijing Tiantan Biological Products Corporation Limited (北京天坛生物制品股份有限公司) (600161.SH) reported a net profit of 175.6 million yuan in the first quarter of 2022, down 22.8% year-on-year.

Meanwhile, the company posted 704.8 million yuan in revenue, down 16.8% year-on-year.

At the end of the reporting period, it had 11.9 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 11.9%.